Dr. Ana-Maria Orbai, MD

Dr. Orbai practices at Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System.

Dr. Orbai's NPI, 1255516332, was assigned on January 8, 2008. Dr. Orbai holds Maryland license P21909.

Dr. Orbai's primary practice is Johns Hopkins Bayview Medical Center, at 4940 Eastern Avenue, Baltimore, MD 21224 in Baltimore City. The practice phone is (410) 550-0123.

Dr. Orbai's primary practice is Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System. Dr. Orbai is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Orbai to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Orbai practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Orbai's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Orbai is licensed in Maryland.

CMS data shows 310 Medicare services from Dr. Orbai across 4 procedure codes in 2024, for 123 Medicare patients. Medicare paid $17,968 for them.

CMS counts 123 Medicare patients who saw Dr. Orbai in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have arthritis, and 70% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Orbai's median patient age at 68, with 61% women.

In 2024, Dr. Orbai wrote 504 Medicare Part D claims for 90 patients. 39% of them were for generic drugs. CMS names the drug for 392 of them, across 17 drugs with 11 or more claims each, at $2,001,733 in total drug cost. In 2023, CMS named 389 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Orbai for performance year 2024, reported as part of a group. CMS lists Dr. Orbai as offering telehealth.

CMS Open Payments shows 158 general payments to Dr. Orbai from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Novartis Pharmaceuticals Corporation paid the most, $58,024. It also lists 19 research payments totaling $20,791 from 2019 to 2022.